Singapore-based generic pharmaceutical firm Eywa Pharma Pte Ltd has secured $30 million from a group of investors including Eight Roads Ventures India, the proprietary investment arm of FIL, Fidelity International Ltd, and the US-based F-Prime Capital Partners.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
